2nd Quarter - Report
GRIDIRON PUBLIC AFFAIRS, LLC for AGIOS PHARMACEUTICALS
Client
Income
$10,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to patient access to innovative therapies, H.R. 5187 - Sickle Cell Disease H.R. 5094 - Orphan Drugs
| Lobbyist | Covered position, as disclosed |
|---|---|
| GREG CHESMORE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.